Analysts Viewpoint Iterum Therapeutics Plc [ITRM] stock for 10,854 USD was acquired by Dunne Michael W. The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Stock Earnings ITRM stock rated a Hold by Gabelli & Co Iterum Therapeutics Plc’s filing revealed that its Director Dunne Michael W. acquired Company’s shares for reported $10854.0 on Aug 08